As previously reported [13], Probio-M9 substantially reduced the inflammatory response, infiltration of CD68+ macrophages in the non-tumor area, expression of TNF-α and IL-6, and number of Ki67-positive proliferating cells in the tumor area. The gene discussed is IL6; the disease is neoplasm.